Health Canada approved Opdivo injection (nivolumab), the first and only immuno-oncology therapy approved in Canada for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy. The approval was made under the Health Canada Priority Review process, after having met the criteria of substantial...
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
